Tin tức & Cập nhật
Xem bài viết Thần kinh
Xem
Chỉ hiển thị Multimedia

X-TOLE OLE interim analysis shows long-term efficacy of novel agent for focal epilepsy
10 Apr 2025
bởiAudrey Abella
Interim data from the ongoing 7-year open-label extension (OLE) of the phase IIb X-TOLE study reflect the long-term efficacy and safety of azetukalner, an investigational, potent Kv7 potassium channel opener, for the treatment of adults with focal epilepsy.
10 Apr 2025

25M people seen to live with Parkinson’s disease in 2050
03 Apr 2025
bởiStephen Padilla
At least 25 million individuals around the world are expected to live with Parkinson’s disease (PD) by the year 2050, posing a substantial public health challenge not just for patients and their families, but for caregivers, communities, and society as well, according to a study.
03 Apr 2025







